O-1 Visa for Founders & Entrepreneurs: Complete 2026 Guide
The O-1 visa is the strongest US immigration path for startup founders, entrepreneurs, and operating executives. Unlike the H-1B's lottery and labor-certification requirements, the O-1 evaluates the individual's extraordinary ability directly — and Google's traffic data shows founder-focused content is where Talent Visas has the most established topical authority. This complete guide consolidates every founder-relevant O-1 article on the site: qualification frameworks, evidence strategies for founders without traditional credentials, equity-as-salary documentation, agent vs employer petitioner choices, comparisons with the E-2 and H-1B, and current 2026 USCIS adjudication patterns for founder petitions.
General
- Building an O-1 Case as a Startup Founder in April 2026
- Critical Role Criterion for O-1A: Startup Founders Edition
- How Startup Founders Qualify for the O-1 Visa
- Does Raising Venture Capital Help Your O-1 Visa Case?
- Can a Solo Founder With No Employees Get an O-1 Visa?
- How to Use Your Startup's Press Coverage for Your O-1 Application
- What Counts as 'Critical Role' for a Startup Founder?
- From Station F to Silicon Valley: One Founder's O-1 Visa Journey
- How a Startup CTO With No Ivy League Degree Got an O-1 Visa
- O-1 Visa at 28: How a Young Founder Proved Extraordinary Ability
- Building a U.S. Career as a Polish biotech CEO — April 2026
- February 2026: Networking Strategy for O-1 venture capitalists
- December 2025: Korean founder Shares O-1 Tips
- O-1A Judging Criterion: A venture capitalist's Guide for November 2025
- Building a U.S. Career as a Polish venture capitalist — October 2025
- O-1A Judging Criterion: A biotech CEO's Guide for September 2025
- From Denial to Approval: founder's O-1 Journey — August 2025
- Building a U.S. Career as a Polish biotech CEO — August 2025
- June 2025: Networking Strategy for O-1 venture capitalists
- April 2025: Korean founder Shares O-1 Tips
- O-1A Judging Criterion: A venture capitalist's Guide for March 2025
- Building a U.S. Career as a Polish venture capitalist — February 2025
- O-1A Judging Criterion: A biotech CEO's Guide for January 2025
- Building a U.S. Career as a Polish biotech CEO — December 2024
- October 2024: Networking Strategy for O-1 venture capitalists
- August 2024: Korean founder Shares O-1 Tips
- O-1A Judging Criterion: A venture capitalist's Guide for August 2024
- Building a U.S. Career as a Polish venture capitalist — July 2024
- O-1A Judging Criterion: A biotech CEO's Guide for May 2024
- From Denial to Approval: founder's O-1 Journey — April 2024
- Building a U.S. Career as a Polish biotech CEO — April 2024
- March 2024: Networking Strategy for O-1 venture capitalists
- December 2023: Korean founder Shares O-1 Tips
- O-1A Judging Criterion: A venture capitalist's Guide for December 2023
- Building a U.S. Career as a Polish venture capitalist — November 2023
- O-1A Judging Criterion: A biotech CEO's Guide for September 2023
- From Denial to Approval: founder's O-1 Journey — September 2023
- Building a U.S. Career as a Polish biotech CEO — August 2023
- July 2023: Networking Strategy for O-1 venture capitalists
- May 2023: Korean founder Shares O-1 Tips
- O-1A Judging Criterion: A venture capitalist's Guide for April 2023
Pre-Revenue Startups
venture capitalists in biotech
- O-1A for venture capitalists in biotech: March 2026 Evidence Guide
- O-1A for venture capitalists in biotech: July 2025 Evidence Guide
- O-1A for venture capitalists in biotech: November 2024 Evidence Guide
- O-1A for venture capitalists in biotech: April 2024 Evidence Guide
- O-1A for venture capitalists in biotech: August 2023 Evidence Guide